TEMPEST THERAPEUTICS INC (TPST:NASDAQ)
$1.11 0.01 (0.9091%)
Analysed TEMPEST THERAPEUTICS INC (TPST:NASDAQ) News Sources
Tempest Reports Year End 2025 Financial Results and Provides Business Update
30-03-2026
yahoo.com
New Strong Buy Stocks for April 10th
10-04-2026
yahoo.com
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
22-04-2026
yahoo.com
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
29-04-2026
yahoo.com
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
14-05-2026
yahoo.com
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
29-05-2026
yahoo.com
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
04-06-2026
yahoo.com
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
15-07-2026
yahoo.com
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
21-07-2026
yahoo.com
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
13-08-2026
yahoo.com
What is the current price of TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The current price of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is $1.11.
TEMPEST THERAPEUTICS INC (TPST:NASDAQ) absolute price change since previous trading day?
The absolute price change of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) since the previous trading day is $0.01.
TEMPEST THERAPEUTICS INC (TPST:NASDAQ) percentage price change since previous trading day?
The percentage price change of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) since the previous trading day is 0.9091%.
What is the most recent average sentiment score for TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The most recent average sentiment score for TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The most recent sentiment for TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is .
SEC-8K** Filing Available For TEMPEST THERAPEUTICS INC (TPST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.